Eli Lilly Aktie
WKN: 858560 / ISIN: US5324571083
|
15.06.2026 18:30:00
|
Should You Buy Eli Lilly Stock Now or Wait for a Dip?
Eli Lilly (NYSE: LLY) is back up to $1 trillion in market cap. This year, the stock is up a modest 5%, but over five years, its returns are incredibly impressive at over 400%. The healthcare giant has become a huge player in the GLP-1 weight loss market, and investors have been loading up on its shares amid the opportunities in that space.What may be troubling, however, is its valuation. That's because it's now trading at 40 times its trailing earnings, which isn't exactly cheap. Is Eli Lilly stock still a good buy today, or are you better off waiting for a possible pullback in its price?Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Eli Lilly
Analysen zu Eli Lilly
| 04.02.26 | Eli Lilly Buy | Goldman Sachs Group Inc. | |
| 20.12.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
| 31.10.24 | Eli Lilly Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
| Eli Lilly | 1 052,20 | -0,06% |
|
Letzte Top-Ranking Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.